As of 2026-03-30, 长春长生狂犬病疫苗's data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 4 competitors in the same category, 长春长生狂犬病疫苗's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
长春长生狂犬病疫苗's Mention Rate is 0.00%, lower than 0.6% of competitors
长春长生狂犬病疫苗's First Mention is 0.00%, lower than 0.9% of competitors
长春长生狂犬病疫苗's Preferred Rate is 0.00%, lower than 100.0% of competitors
长春长生狂犬病疫苗's Positive Rate is 0.00%, lower than 8.9% of competitors
长春长生狂犬病疫苗's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 阿阿莫西林 | 0% | 0% | 0% | 0% | 0% | View Details |
| 安安宫牛黄丸 | 0% | 0% | 0% | 0% | 0% | View Details |
| 赫赫赛汀（曲妥珠单抗） | 0% | 0% | 0% | 0% | 0% | View Details |
| 格格列卫（甲磺酸伊马替尼片） | 0% | 0% | 0% | 0% | 0% | View Details |
| 长长春长生狂犬病疫苗 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
